Follow on Telegram

science/health

FDA Issues First AI-Focused cGMP Warning Letter, Signaling Tighter Regulatory Scrutiny

FDA's First AI-Focused cGMP Warning Letter The U.S. Food and Drug Administration (FDA) has issued its first warning letter specifically addressing artificial intelligence systems under current Good Manufacturing Practice (cGMP) regulations, marking a significant shift in regulatory approach. What This Means for Manufacturers The letter signals that

New Gene-Based Approaches Target Previously Overlooked Gap in Huntington's Disease Progression

A new generation of therapies is emerging that targets a previously overlooked stage in Huntington's disease progression. These approaches aim to intervene at a newly identified gap between the disease's molecular cascade and its neurological consequences, offering potential new avenues for treatment. Huntington's disease

CMS Signals Major Shift in Payment Policies for Clinical Software and AI in Healthcare

The Centers for Medicare & Medicaid Services (CMS) has signaled its intent to revamp how it pays for clinical software and artificial intelligence tools used in healthcare settings. This move could have significant implications for how medical technology companies develop and price their products, as payment structures from CMS often

Researchers Uncover How Common Gut Bacteria Triggers Colon Cancer, Design Blocking Therapy

Researchers have solved a longstanding mystery surrounding how certain gut bacteria may contribute to colorectal cancer development. A team has identified the specific mechanism by which a bacterial toxin associated with colorectal cancer attacks the colon's protective barrier. The toxin was found to first bind to a receptor

New AI Model Combines Electronic Health Records and Genetics to Predict 348 Diseases

A new AI model is showing promise in predicting a wide range of diseases by analyzing both electronic health records and genetic information together. What the Model Does The system can predict 348 different diseases by combining two major data sources: * Electronic Health Records (EHR): Patient medical histories, test results,

Insilico Medicine Partners with Bora in $2.5 Billion AI Drug Discovery Deal

AI Drug Discovery Collaboration Reaches $2.5 Billion Insilico Medicine, a pioneer in AI-powered drug discovery, has entered into a significant partnership with contract development and manufacturing organization (CDMO) Bora. The deal, valued at $2.5 billion, aims to accelerate the development of novel therapeutics through artificial intelligence. What This

Anthropic Expands Claude AI into Drug Discovery and Medical Research

Overview Anthropic, the company behind the Claude AI assistant, is expanding into drug discovery and medical research applications. This move represents a significant diversification beyond their existing enterprise chatbot services. Industry Context The intersection of large language models and healthcare has become an active area of development, with multiple AI